Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.

Clinical trial NCT06974474 · RECRUITING

Trial details

NCT number: NCT06974474
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Arthritis

Start date: 2024-06-18
Primary completion: 2025-11-27
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.